Migraine expansion?

Discussion in 'Allergan' started by anonymous, Oct 15, 2019 at 6:17 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Curious on this role as I have heard it pays very little and they are not looking for experienced reps. Any truthful insight?
    What is the most they woukd pay for this role? Also i see the drug is not yet approved .
     

  2. anonymous

    anonymous Guest



    Pays $75K, bonus will be lower as it’s only one drug. No experience needed and unless the internal candidates are brain dead ( completely possible) outside applicants have ZERO chance. And yes drug isn’t approved.

    The entire thing is bullshit. They are trying to keep people from leaving because we all know everyone will be canned after the Abbvie deal closes.
     
  3. anonymous

    anonymous Guest

    I was told midrange was 80. Which is still too low. when will territories be filled?
     
  4. anonymous

    anonymous Guest

    80K? Is that a month? WTF?
     
  5. anonymous

    anonymous Guest

    No, that’s per year , This will mainly be calling on primary care in a generic market, Insurance will require patients to fail three generic migraine drugs before they would even be allowed to try this new branded expensive Allergan migraine drug. Hearing 80 K max salaries this is low compared to other big neurology companies, But 80% of calls are the primary care
     
  6. anonymous

    anonymous Guest

    Funny how none of this sounds like anything I have been told
     
  7. anonymous

    anonymous Guest


    What have you heard then? We’d love a good laugh.
     
  8. anonymous

    anonymous Guest

    This acute CGRP drug will
    be 2nd to market behind
    Biohaven’s acute CGRP
    oral tablet which is due to
    be approved in Dec.
    80% of the call points will
    be to primary care.
     
  9. anonymous

    anonymous Guest

    Don't forget Eli Lilly's acute migraine drug was approved last Friday. Another IV CRGP coming from Lundbeck early 2020 as well.
     
  10. anonymous

    anonymous Guest

    Botox for migraines is the easiest drug/medication you will ever sell. Lot of competition coming into the market but very easy to sell against.

    Allergan used to be a good company but still has old Forrest/Actavis leadership which has ruined its reputation. The Botox franchise however still has good people but run very old school and the entire company would benefit with a newer school approach to running the business. They do however create reps that are trained well but the low compensation makes them just a stepping stone.
     
  11. anonymous

    anonymous Guest

    So funny how predictable Cafe Pharma can be....all lies and negatively. The truth 100k-120k base with great bonus potential. Myself personally, 5-6 years in pharma 3 at specialty. 100k salary and roughly 50k in bonus (Top 30%). I know reps that will make 100k in bonuses this year. It’s a great opportunity for hungry specialty reps. If you’re an old entitled rep looking to coast for a 150k salary, then it’s not for you.
     
  12. anonymous

    anonymous Guest

    Old entitled rep here. Making $210k at plan. You work twice as hard and for way less dough.
    Let’s see if you ever become an older rep. Your days in Pharma are numbered.
     
  13. anonymous

    anonymous Guest

    Awesome and true - #metoo
     
  14. anonymous

    anonymous Guest

    Back to the OP!

    I think the differentiation here is between the upcoming legacy Forest launch of ubrogepant acute pills and the legacy Allergan chronic migraine injection Botox.

    Are there any teams selling both?

    I can tell you for certain, the Forest side pays far less. They’re geared toward PC.
     
  15. anonymous

    anonymous Guest

    THATS WHAT IVE HEARD. Hopefully it’s not just for a good laugh
     
  16. anonymous

    anonymous Guest

    Quoted at 85 base with 30 at plan. No experience.